Henry T. K. Yang
Neil R. Patel
Treatment and management of seizures and epilepsy, as well as EEG interpretation
Dr. Patel's research interests are in working with driving simulators to assess epilepsy patients' ability to safely use vehicles.
<p>Neil Patel, MD, is an attending physician and Assistant Professor, Neurology and Epilepsy at Montefiore Einstein. As an epilepsy neurologist, Dr. Patel focuses on the treatment and management of seizures and epilepsy, as well as electroencephalogram (EEG) interpretation.</p><p>A graduate of Rutgers University, Dr. Patel completed his Bachelor of Science in genetics in 2013 and his Doctor of Medicine in 2018. He then came to Montefiore Einstein, where he completed his internal medicine internship in 2019, his adult neurology residency in 2022 and his epilepsy fellowship in 2023.</p><p>Building on his clinical focus, Dr. Patel's research interests include working with driving simulators to assess epilepsy patients' ability to safely use vehicles. His work has been published in peer-reviewed journals, abstracts and case reports.</p><p>Dr. Patel is board certified by the American Board of Psychiatry and Neurology (ABPN). In 2022, he won the Leo M. Davidoff Society Award for Outstanding Achievement in the Teaching of Medical Students.</p>
Michael S. Tau
Stephen W. Briggs
Elissa G. Yozawitz
<p>Pediatric neurology, epilepsy, neonatal neurology.</p>
Dr. Yozawitz focuses on the management of neonatal neurology and pediatric epilepsy, particularly children and adolescents with difficult-to-treat seizures. She specializes in a variety of neurological conditions diagnosed in the newborn period, including hypoxic-ischemic encephalopathy, stroke, and seizures. She has expertise in EEG and advanced medical treatments. She provides care from the neonatal period through adolescence.
Dr. Yozawitz’s research is focused on neonatal seizures and early-life epilepsies, including infantile spasms. She is involved in multicenter studies to improve the diagnosis, treatment, and outcomes for children with epilepsy. She is also involved in assessing EEG changes during anesthesia.
<p>Elissa G. Yozawitz, MD, is Director of Neonatal Neurology at Children’s Hospital at Montefiore Einstein and Professor of Neurology and Pediatrics at our Albert Einstein College of Medicine. Dr. Yozawitz focuses on the neurological management of children, from the neonatal period through adolescence, particularly those with difficult-to-treat seizures. She also specializes in the diagnosis and treatment of hypoxic-ischemic encephalopathy, stroke and seizures in the newborn. Dr. Yozawitz’s expertise includes electroencephalography (EEG) and state-of-the-art treatments.</p><p>After obtaining a Bachelor of Arts in psychology and in health and society from the University of Rochester in 2001, Dr. Yozawitz earned a Doctor of Medicine from the State University of New York Upstate Medical University in 2005. She completed a pediatric residency at Schneider Children’s Hospital in 2007, followed by a residency in pediatric neurology at Montefiore Einstein in 2010. Dr. Yozawitz remained at Montefiore Einstein to complete a fellowship in clinical neurophysiology in 2011.</p><p>Dr. Yozawitz’s research focuses on improving the identification and efficacy of treating early-life epilepsies, including infantile spasms. Her research also explores EEG changes during anesthesia. Dr. Yozawitz participated in multicenter studies, functioned as site principal investigator and co-investigator for multiple research projects, presented her research findings at national and international scientific meetings, published in numerous peer-reviewed journals and authored several book chapters. She served as a reviewer for medical journals including <em>Epilepsia, Epileptic Disorders, Neurology</em> and the <em>New England Journal of Medicine</em>, among others. For several years, Dr. Yozawitz participated in the work of international committees tasked to revise nosology and treatment guidelines for neonatal and childhood epilepsy.</p><p>Dr. Yozawitz is board certified by the American Board of Psychiatry and Neurology in Epilepsy and Neurology, with special certification in Child Neurology. She is a member of the American Academy of Neurology, the American Epilepsy Society and the Child Neurology Society. Dr. Yozawitz repeatedly has been named in Castle Connolly’s “Regional Top Doctor,” “Top Doctors: New York Metro Area.” She additionally has been listed in <em>New York Magazine’s</em> “Top Doctors” for multiple years.</p>
Shlomo Shinnar
<p>Dr. Shlomo Shinnar is a neurologist, pediatrician and epidemiologist. His expertise focuses on comprehensive epilepsy management, child neurology and epilepsy with a focus on long term studies the prognosis of childhood seizures disorders. He is also an experienced clinical trialist and is the co-director of the Einstein NeuroNEXT cener of Excellence for Clinical Trials in Neurology.<br /><br />Dr. Shinnar conducts research on a variety of topics relating to childhood seizures, including when to initiate and discontinue antiepileptic drug therapy, prognosis following a first seizure, and prognosis following discontinuation of medications in children with seizures. He is also interested in the comorbidities of epilepsy and its impact on chilren and families. He current studies focus on status epilepticus, a life-threatening condition of persistent continuous and unremitting brain seizure lasting longer than 30 minutes. He is also involved in research in autism, an increasingly common neurological condition in childhood.<br /><br />His current research focuses on the consequences of prolonged febrile seizures, the most common seizure seen in children and on the long term outcomes of childhood absence (petit-mal) seizures which are the most common form of epilepsy in children. He is also on the executive commitee of the recentlyfunded ESETT (Established Status Epilepticus Treatment Trial) trial which seeks to determine the optimal therapy for convulsive status epilepticus inchildren and adults when first line therapy with a benzodiazepine has failed.</p>
<p>Dr. Shinnar is the senior editor of the book <em>Childhood Seizures</em> and co-editor of the book <em>Febrile Seizures</em>. He has published over 185 original papers and over 125 reviews and chapters. He is the recipient of the prestigious Research Recognition Award of the American Epilepsy Society and the CURE research award. His continuing research on the Consequences of Prolonged Febrile Seizures in Children (FEBSTAT) study was recently recognized with the prestigious Javits award by the NINDS.<br /><br /></p>
<p>Most recent publications:</p>
<p>ORIGINAL PAPERS:</p>
<p>Sillanpaa M, Shinnar S. SUDEP and other causes of mortality in childhood-onset epilepsy<span style="text-decoration: underline;">. Epilepsy & Behavior</span> 2013;28:249-255. PMID: 23746924</p>
<p> Hesdorffer DC, Shinnar S, Lewis DV, Nordli DR Jr, Pellock JM, Moshe SL, Shinnar RC, Litherand C, Bagiella E, Frank LM, BelloJA, Chan S, Masur D, Macfall J, Sun S and the Consequences of Prolonged Febrile Seizures (FEBSTAT) Study Team. Risk Factors for Febrile Status Epilepticus: A case control study. <span style="text-decoration: underline;">J Pediatr</span> 2013; 163:1147-1151. PMID: 23809042 PMCID: PMC3989363</p>
<p> Masur D, Shinnar S, Cnaan A, Shinnar RC, Clark P, Wang J, Weiss EF, Hirtz DG, Glauser TA, Childhood Absence Epilepsy Study Group. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. <span style="text-decoration: underline;">Neurology</span> 2013; 81:1572-1580. PMID: 24089388. PMCID: PMC3980500</p>
<p> Brown FC, Westerveld M, Langfitt JT, Hamberger M, Hamid H, Shinnar S, Sperling MR, Devinsky O, Barr W, Tracy J, Masur M, Bazil CW, Spencer SS. Influence of anxiety on memory performance in temporal lobe epilepsy. <span style="text-decoration: underline;">Epilepsy & Behavior</span> 2014; 31:19-24. PMID: 24291525 PMCID: PMC3946774.</p>
<p> Lewis DV, Shinnar S, Hesdorffer DC, Bagiella E, Bello JA, Chan S, Xu Y, MacFall J, Gomes WA, Moshe SL, Mathern GW, Pellock JM, Nordli DR Jr, Frank LM, Provenzale J, Shinnar RC, Epstein LG, Masur D, Litherand C, Sun S; FEBSTAT Study Team. Hippocampal sclerosis after febrile status epilepticus: The FEBSTAT study<span style="text-decoration: underline;">. Ann Neurol</span> 2014;75:178-185. PMID# 24318290 NIHMSID# 569823 PMCID: PMC3980500</p>
<p> Hussain SA, Shinnar S, Kwong G, Lerner JT, Matsumoto JH, Wu JY, Sields WD, Sankar R. Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone. Epilepsia 2014;55:103-107. PMID 24446954 OMCID: PMC3904676</p>
<p> Hamid H, Blackmon K, Cong X, Dziura J, Atlas LY, Vickrey BG, Berg AT, Bazil CW, Langfitt JT, Walczak TS, Sperling MR, Shinnar S, Devinsky O. Mood anxiety and incomplete seizure control affect quality of life after epilepsy surgery. <span style="text-decoration: underline;">Neurology</span> 2014; 82:887-894. PMID 24489129 PMCID: PMC3959755.</p>
<p> Seinfeld S, Shinnar S, Sun S, Hesdorffer DC, Deng X, Shinnar RC, O’Hara K, Nordli DR Jr, Frank LM, Gallentine W, Moshe SL, Pellock JM and FEBSTAT Study Team. Emergency management of febrile status epilepticus: results of the FEBSTAT study<span style="text-decoration: underline;">. Epilepsia</span> 2014; 55:388-395. PMID 24502379 PMCID: PMC3937844.</p>
<p> Mendley SR, Matheson MB, Shinnar S, Lande MB, Gerson AC, Butler RW, Warady BA, Furth SL, Hooper SR. Duration of chronic kidney disease reduces attention and executive function in pediatric patients. <span style="text-decoration: underline;">Kidney Int</span> 2014; 87:800-806.] PMID 25252026</p>
<p> Valicenti-McDermott M, Lawson K, Hottinger K, Seijo R, Schechtman M, Shulman L, Shinnar S. Parental Stress in Families of Children with Autism and Other Developmental Disabilities. <span style="text-decoration: underline;">J Child Neurol</span> 2015 April 10 [epub ahead of print). PMID: 25862740.</p>
<p> Krumholz A, Wiebe S, Groseth GS, Gloss DS, Sanchez AM, Kabir AA, Liferidge AT, Martello JP, Kanner AM, Shinnar S, Hopp JL, French JA. Evidence-based guideline: Management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. <span style="text-decoration: underline;">Neurology</span> 2015;84:1805-1713. PMIDL 25901057</p>
<p>RECENT REVIEWS:</p>
<p> Gomes WA, Shinnar S. Prospects for imaging-related biomarkers of human epileptogenesis: A critical review. <span style="text-decoration: underline;">Biomark Med</span> 2011;5:599-606. PMID:22003908. PMCID: 3235417.</p>
<p> Shinnar S. Prognostic factors for recurrence after a first unprovoked seizure in childhood. In Arts WF, Arzimanoglou A, Brouwer OF, Camfield C, Camfield P eds. <span style="text-decoration: underline;">Outcome of Childhood Epilepsies.</span> Progress in Epileptic Disorders 2013;12:25-31.</p>
<p> Bleck T, Cock H, Chamberlain J Cloyd J, Connor J, Elm J, Fountain N, Jones E, Lowenstein D, Shinnar S, Silbergleit R, Treiman D, Trinka E, Kapur J. The established status epilepticus trial 2013. <span style="text-decoration: underline;">Epilepsia</span> 2013 54 (suppl 6): 89-92. PMID 24001084 PMCID: PMC4048827</p>
<p> Patterson KP, Baram TZ, Shinnar S. Origins of Temporal Lobe Epilepsy: Febrile seizures and Febrile Status Epilepticus. <span style="text-decoration: underline;">Neurotherapeutics</span> 2014; 11:242-250. PMID: 24604424 PMCID: PMC3996115</p>
Elayna O. Rubens
Jillian L. Rosengard
<p class="MsoNormal" style="margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; line-height: 16.8667px;">Jillian L. Rosengard, MD, is an attending physician and Associate Professor of Neurology at Montefiore Einstein. She specializes in the diagnosis and management of seizures and epilepsy. She has a particular interest in treating patients with intractable epilepsy and caring for women with epilepsy during their pregnancies, as well as medical education.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; line-height: 16.8667px;"> </p>
<p class="MsoNormal" style="margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; line-height: 16.8667px;">After obtaining her Bachelor of Arts at Harvard in 2008, Dr. Rosengard earned her Doctor of Medicine at Mount Sinai School of Medicine in 2012. She completed an internship in internal medicine at New York University Langone Medical Center in 2013 before completing her residency in neurology at Mount Sinai Medical Center in 2016, where she served as Chief Resident. Dr. Rosengard then completed a fellowship in clinical neurophysiology at Einstein in 2017.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; line-height: 16.8667px;"> </p>
<p class="MsoNormal" style="margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; line-height: 16.8667px;">Dr. Rosengard's research focuses on the impact of Covid-19 on patients with epilepsy as well as seizure prediction. She also participates in drug trials for new anti-seizure medications through Montefiore’s Clinical Research Center. She has been Principal Investigator and Co-Principal Investigator on several research projects, and her work has been published in numerous peer-reviewed journals and textbooks. Dr. Rosengard has given national presentations and has been a reviewer for scientific journals including <em>Neurology, Epilepsy & Behavior </em>and the<em> Journal of the Neurological Sciences.</em></p>
<p class="MsoNormal" style="margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; line-height: 16.8667px;"><em> </em></p>
<p class="MsoNormal" style="margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; line-height: 16.8667px;">Dr. Rosengard is board certified in Neurology and Epilepsy by the American Board of Psychiatry and Neurology. She is a member of the American Academy of Neurology and the American Epilepsy Society. In 2023, Dr. Rosengard was elected into the Leo M. Davidoff Society for outstanding achievement in the teaching of medical students, and she has been named a New York Super Doctors Rising Star for several years.</p>
Dr. Rosengard specializes in the diagnosis and management of seizures and epilepsy. She has a particular interest in treating women with epilepsy during their pregnancies as well as medical education.<br />
Dr. Rosengard's research focuses on the Covid-19 pandemic's inpatient on patients with epilepsy as well as seizure prediction. She also participates in drug trials for new anti-seizure medications through Montefiore Clinical Research Center.<br /><quillbot-extension-portal></quillbot-extension-portal>